Distinct profiles for mitochondrial t-RNAs and small nucleolar RNAs in locally invasive and metastatic colorectal cancer.
By: Lai Xu, Joseph Ziegelbauer, Rong Wang, Wells W Wu, Rong-Fong Shen, Hartmut H Juhl, Yaqin Zhang, Amy S Rosenberg

OBP/DBRR-III, FDA.
2015-9-20; doi: 10.1158/1078-0432.CCR-15-0737
Abstract

Purpose

To gain insight into factors involved in tumor progression and metastasis, we examined the role of non-coding RNAs (ncRNAs) in the biological characteristics of colorectal carcinoma (CRC), in paired samples of tumor together with normal mucosa from the same CRC patient. The tumor and healthy tissues samples were collected and stored under stringent conditions, thereby minimizing warm ischemic time.

Experimental

We focused particularly on distinctions among high stage tumors and tumors with known metastases, performing RNA-Seq analysis which quantifies transcript abundance and identifies novel transcripts.

Results

In comparing 35 CRCs, including 9 metastatic tumors (metastases to lymph nodes and lymphatic vessels (LN/LV)), to their matched healthy control mucosa, we found a distinct signature of MT-tRNAs and snoRNAs for metastatic and high stage CRC. We also found the following: 1) MT-TF (phenylalanine) and snord12B expression correlated with a substantial number of miRNAs and mRNAs in 14 CRCs examined; 2) a miRNA signature of oxidative stress, hypoxia and a shift to glycolytic metabolism in 14 CRCs, regardless of grade and stage, and 3) heterogeneous MT-tRNA/snoRNA fingerprints for 35 pairs.

Conclusions

These findings could potentially assist in more accurate and predictive staging of CRC including identification of those CRC likely to metastasize.



Copyright © 2015, American Association for Cancer Research.

PMID:26384739






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements